12 Followers on Owler
Ascletis is engaged in discovering and developing specialty therapeutics for the treatment of cancer and infectious diseases... Read more
OverviewCompetitorsFundingInvestmentsNews & Insights
Ascletis is engaged in discovering and developing specialty therapeutics for the treatment of cancer and infectious diseases... Read more
Ascletis Pharma President & CEO: Jinzi J. Wu

President & CEO

Jinzi J. Wu

CEO Approval Rating

68/100

2011

PublicHong Kong Stock Exchange01672

Health Care Equipment & Services
Health Care Supplies
5047 NAICS listing

Annual Revenue
<$1M
Employees
<10
Funding
$355M
Investments
2

News

Funding
Feb 06, 2026
ACN Newswire
Ascletis Pharma received $100M in Post-IPO Equity Funding

Ascletis Pharma Competitors

1Kite Pharma
2Juno Therapeutics
3Theravectys
4bluebird bio
5Inovio
6Jounce
7Novartis
8Pfizer
9Immune Design
10Amgen
Unlock 21 + competitors

Trending Companies